Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
| Market Capitalization | $77.7774 million |
| P/E Ratio | |
| P/E Growth Ratio | |
| Book Value | 0.023 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.027 |
| EBITDA | -12,730.937 |
| Profit Margin | 0 |
| Operating Margin TTM | -4.5594 |
| Return on Assets TTM | -0.7317 |
| Return on Equity TTM | -1.4504 |
| Revenue TTM | 6,218.558 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2013-12-31 | 0 | 0.249 | -0.249 | 0.249 |
| 2014-12-31 | 20.925 | 29.376 | -8.451 | 30.144 |
| 2015-12-31 | 122.42 | 140.17 | -17.75 | 138.864 |
| 2016-12-31 | 8.022 | 32.828 | -24.806 | 4,157.767 |
| 2017-12-31 | 243.798 | 437.697 | -193.899 | 13,850.499 |
| 2018-12-31 | 558.382 | 353.566 | 204.816 | 14,969.361 |
| 2019-12-31 | 3,626.427 | 1,500.537 | 2,125.89 | 12,300.798 |
| 2020-12-31 | 2,447.761 | 6,330.176 | -3,882.415 | 10,485.916 |
| 2021-12-31 | 6,218.337 | 6,618.948 | -400.611 | 27,952.472 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2015-12-31 | 5,580.352 | 6,011.139 | 134.648 | 51.004 | 5,211.631 | |
| 2016-06-30 | 5,580.352 | 6,011.139 | 134.648 | 51.004 | ||
| 2016-12-31 | 3,046.054 | 3,767.873 | 528.022 | 5,479.612 | ||
| 2017-12-31 | 12,424.913 | 21,595.904 | 567.27 | 35,138.519 | ||
| 2018-12-31 | 6,390.538 | 22,282.294 | 5,777.902 | 2,776.45 | 38,222.883 | |
| 2019-12-31 | 2,800.318 | 22,663.609 | 5,389.649 | 3,227.318 | 46,528.519 | |
| 2020-12-31 | 6,047.091 | 19,120.608 | 5,468.437 | 3,255.754 | 71,794.123 | |
| 2021-12-31 | 7,184.405 | 29,314.106 | 1,555.494 | 109,950.694 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2013-12-31 | -0.249 | -2,565.126 | 0.012 | |||
| 2014-12-31 | -9.953 | -2,565.126 | 0.012 | |||
| 2015-12-31 | -138.864 | -2,565.126 | 0.012 | 0.001 | ||
| 2016-12-31 | -4,584.239 | -2,565.126 | 3,046.053 | 0.001 | 3,046.054 | 0 |
| 2017-12-31 | -15,076.076 | -7,538.133 | 9,378.859 | 3,046.054 | 12,424.913 | |
| 2018-12-31 | -16,756.036 | -8,173.313 | -6,034.375 | 12,424.913 | 6,390.538 | |
| 2019-12-31 | -15,054.381 | -10,166.956 | -3,590.22 | 6,390.538 | 2,800.318 | |
| 2020-12-31 | -30,779.581 | -9,621.58 | 3,246.773 | 2,800.318 | 6,047.091 | |
| 2021-12-31 | -30,030.967 | -22,377.916 | 1,137.314 | 6,047.091 | 7,184.405 |